"The Dark Index"

Cytyc Corp. Raising $48 Million To Fund ThinPrep Sales Effort

CEO SUMMARY: Armed with FDA premarket approval, Cytyc must now overcome significant obstacles to introduce its ThinPrep Pap smear system into widespread clinical usage.

ANOTHER WELL-FINANCED competitor will soon enter the Pap smear marketplace. Cytyc Corporation is offering 3,000,000 shares to the public with the goal of raising $48.2 million.

Cytyc will use $25 million of the

Subscriber-Only Content. Please Log In.

You are trying to access subscribers-only content. If you are a subscriber, please log in.

If you are not a subscriber, click here to see subscription offers.

Subscribers will have instant access to the Dark Report library, 1997 - the present, giving you the most convenient, accessible archive available in laboratory business intelligence today!

To read our FREE article previews, go to The Dark Report Insider.

Tags: , , , , , , , , , , , , , ,

Enter Your Login Credentials
This setting should only be used on your home or work computer.


Send this to friend